Category: Asian Pacific J Cancer Prev

One image was duplicated in eight papers. Yes, eight.

A cancer journal has retracted a 2014 paper after discovering one image had been duplicated in seven other papers. That’s right—the same image appeared in a total of eight papers.

For some of the papers, the issues went beyond the single image. According to the retraction notice, several papers contained other duplicated images, as well as “overlapping text.”  The notice, published in October 2017 in Asian Pacific Journal of Cancer Prevention (APJCP), is essentially a letter PLOS ONE wrote to several journals, informing them of the issues in the eight papers, all published between 2014 and 2016. The letter mentions that one of the papers—a 2016 analysis in Korean Journal of Physiology (KJPP)—had already been retracted earlier this year. One author of the retracted KJPP paper confessed to using a company to prepare and submit the manuscript. Continue reading One image was duplicated in eight papers. Yes, eight.

Author from China blames translation company for plagiarism in retracted vascular paper

apjcpDo we need a “throwing vendors under the bus” category here at Retraction Watch?

Earlier this year, we reported on the retraction of a paper because of sloppy work by an outside lab. Now, we have the story of a retraction for “negligence” by a translator. Specifically, the author says the passages shared between the retracted 2015 vascular paper and another paper in EMBO Journal are a result of “negligence on the part of the translation company that I trusted to make my manuscript ready for submission.”

Here’s more from the notice in the Asian Pacific Journal of Cancer Prevention, written by Yong Jiang, of Laboratory Medical College, Jilin Medical College, China: Continue reading Author from China blames translation company for plagiarism in retracted vascular paper